328 related articles for article (PubMed ID: 26813047)
21. Oligoclonal analysis of the atopic T cell response to the group 1 allergen of Cynodon dactylon (bermuda grass) pollen: pre- and post-allergen-specific immunotherapy.
Eusebius NP; Papalia L; Suphioglu C; McLellan SC; Varney M; Rolland JM; O'Hehir RE
Int Arch Allergy Immunol; 2002 Mar; 127(3):234-44. PubMed ID: 11979049
[TBL] [Abstract][Full Text] [Related]
22. Multiple grass mixes as opposed to single grasses for allergen immunotherapy in allergic rhinitis.
Gangl K; Niederberger V; Valenta R
Clin Exp Allergy; 2013 Nov; 43(11):1202-16. PubMed ID: 24152153
[TBL] [Abstract][Full Text] [Related]
23. Pretreatment IgE sensitization patterns determine the molecular profile of the IgG4 response during updosing of subcutaneous immunotherapy with timothy grass pollen extract.
Schmid JM; Würtzen PA; Dahl R; Hoffmann HJ
J Allergy Clin Immunol; 2016 Feb; 137(2):562-70. PubMed ID: 26141262
[TBL] [Abstract][Full Text] [Related]
24. Safety Review of 5-Grass Pollen Tablet from Pooled Data of Clinical Trials.
Casale TB; Cox LS; Wahn U; Golden DBK; Bons B; Didier A
J Allergy Clin Immunol Pract; 2017; 5(6):1717-1727.e1. PubMed ID: 28734858
[TBL] [Abstract][Full Text] [Related]
25. Changes in basophil activation during grass-pollen sublingual immunotherapy do not correlate with clinical efficacy.
Van Overtvelt L; Baron-Bodo V; Horiot S; Moussu H; Ricarte C; Horak F; Zieglmayer P; Zieglmayer R; Montagut A; Galvain S; de Beaumont O; Le Gall M; Moingeon P
Allergy; 2011 Dec; 66(12):1530-7. PubMed ID: 21883279
[TBL] [Abstract][Full Text] [Related]
26. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
[TBL] [Abstract][Full Text] [Related]
27. Grass pollen allergens globally: the contribution of subtropical grasses to burden of allergic respiratory diseases.
Davies JM
Clin Exp Allergy; 2014 Jun; 44(6):790-801. PubMed ID: 24684550
[TBL] [Abstract][Full Text] [Related]
28. Phleum pratense alone is sufficient for allergen-specific immunotherapy against allergy to Pooideae grass pollens.
Hejl C; Wurtzen PA; Kleine-Tebbe J; Johansen N; Broge L; Ipsen H
Clin Exp Allergy; 2009 May; 39(5):752-9. PubMed ID: 19222498
[TBL] [Abstract][Full Text] [Related]
29. Magnitude of efficacy measurements in grass allergy immunotherapy trials is highly dependent on pollen exposure.
Durham SR; Nelson HS; Nolte H; Bernstein DI; Creticos PS; Li Z; Andersen JS
Allergy; 2014 May; 69(5):617-23. PubMed ID: 24605984
[TBL] [Abstract][Full Text] [Related]
30. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
Rossi RE; Monasterolo G; Coco G; Operti D
Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
[TBL] [Abstract][Full Text] [Related]
31. Grass pollen immunotherapy: where are we now.
Würtzen PA; Gupta S; Brand S; Andersen PS
Immunotherapy; 2016; 8(4):399-411. PubMed ID: 26973122
[TBL] [Abstract][Full Text] [Related]
32. Both sublingual and supralingual routes of administration are effective in long-term allergen-specific immunotherapy.
Panzner P; Petráš M; Sýkora T; Lesná IK; Liška M
Allergy Asthma Proc; 2011; 32(2):142-50. PubMed ID: 21439167
[TBL] [Abstract][Full Text] [Related]
33. Which allergen extract for grass pollen immunotherapy? An in vitro study.
Marcucci F; Sensi L; Di Cara G; Incorvaia C; Puccinelli P; Scurati S; Frati F
Immunol Invest; 2010; 39(6):635-44. PubMed ID: 20653430
[TBL] [Abstract][Full Text] [Related]
34. 300IR 5-Grass pollen sublingual tablet offers relief from nasal symptoms in patients with allergic rhinitis.
Serrano E; Wahn HU; Didier A; Bachert C
Am J Rhinol Allergy; 2014; 28(6):471-6. PubMed ID: 25335122
[TBL] [Abstract][Full Text] [Related]
35. Grass pollen sublingual immunotherapy tablets provide long-term relief of grass pollen-associated allergic rhinitis and reduce the risk of asthma: findings from a retrospective, real-world database subanalysis.
Devillier P; Wahn U; Zielen S; Heinrich J
Expert Rev Clin Immunol; 2017 Dec; 13(12):1199-1206. PubMed ID: 29072507
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study.
Bufe A; Ziegler-Kirbach E; Stoeckmann E; Heidemann P; Gehlhar K; Holland-Letz T; Braun W
Allergy; 2004 May; 59(5):498-504. PubMed ID: 15080830
[TBL] [Abstract][Full Text] [Related]
37. Key pollen allergens in North America.
White JF; Bernstein DI
Ann Allergy Asthma Immunol; 2003 Nov; 91(5):425-35; quiz 435-6, 492. PubMed ID: 14692424
[TBL] [Abstract][Full Text] [Related]
38. Clinical efficacy of microencapsulated timothy grass pollen extract in grass-allergic individuals.
TePas EC; Hoyte EG; McIntire JJ; Umetsu DT
Ann Allergy Asthma Immunol; 2004 Jan; 92(1):25-31. PubMed ID: 14756461
[TBL] [Abstract][Full Text] [Related]
39. Extensive IgE cross-reactivity towards the Pooideae grasses substantiated for a large number of grass-pollen-sensitized subjects.
Johansen N; Weber RW; Ipsen H; Barber D; Broge L; Hejl C
Int Arch Allergy Immunol; 2009; 150(4):325-34. PubMed ID: 19571564
[TBL] [Abstract][Full Text] [Related]
40. Sublingual immunotherapy for allergic rhinitis: where are we now?
Incorvaia C; Mauro M; Ridolo E
Immunotherapy; 2015; 7(10):1105-10. PubMed ID: 26507464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
